news
Novartis drug Afinitor® gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors
5 September 2011 | By Novartis
The European Commission has approved Afinitor® (everolimus) tablets...
List view / Grid view
Novartis
article
Implementation of high-throughput quality control processs within compound management
31 August 2011 | By Jerome Giovannoni and J.M. Peltier, Novartis
The constant growth of compound collections, combined with screening efforts on more challenging targets, is creating an increasing demand for quality control in order to ensure the integrity of the compound solutions being tested. This is true throughout the early drug discovery pipeline, from hit identification to lead nomination. Novartis…
news
Teva UK Limited launches generic Letrozole tablets
27 July 2011 | By Teva UK Ltd
We are pleased to announce the launch of generic letrozole film-coated tablets...
news
Novartis drug Afinitor® recommended by CHMP for EU approval
22 July 2011 | By Novartis
The Committee for Medicinal Products for Human Use of the EMA adopted a positive opinion for Afinitor® (everolimus) tablets...
news
Novartis begins shipment of Fluvirin®
15 July 2011 | By Novartis
Novartis announced that the Company has started shipping seasonal influenza vaccine to its US customers for the 2011-2012 influenza season...
news
Phase III trial of Novartis drug Afinitor® met primary endpoint of reducing SEGA tumor size in patients with tuberous sclerosis
8 July 2011 | By Novartis
Novartis announced Phase III trial results...
news
Novartis drug Afinitor® met primary endpoint of Phase III study
5 July 2011 | By Novartis AG
Afinitor® in combination with exemestane extended progression-free survival in women with advanced breast cancer...
news
Novartis receives FDA approval for Arcapta(TM) Neohaler(TM)
1 July 2011 | By Novartis
Novartis announced that the US FDA approved once-daily Arcapta(TM) Neohaler(TM) (indacaterol inhalation powder)...
news
Novartis receives approval in Japan for Onbrez® Inhalation Capsules
1 July 2011 | By Novartis
Novartis has received regulatory approval in Japan for Onbrez® Inhalation Capsules (indacaterol)...
news
Novartis Phase III study shows once-daily NVA237 is superior to placebo
30 June 2011 | By Novartis
Results from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237, 50 mcg significantly improved lung function...
news
FDA panel endorses efficacy but not safety of Novartis drug ACZ885 for gouty arthritis
21 June 2011 | By Novartis
FDA panel voted in favor of the overall efficacy but not the overall safety of ACZ885...
news
Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant
16 June 2011 | By Novartis
Construction of this facility represents the most significant Novartis investment in Russia...
news
Novartis application for expanded Menveo® indication from 2 months of age accepted for review by FDA
16 June 2011 | By Novartis
The US FDA has accepted for review its supplemental Biologics License Application...
news
Horizon successfully completes pilot human gene-editing program
14 June 2011 | By Zyme Communications Ltd
Horizon Discovery has announced that it has successfully completed an eighteen month pilot program with Novartis...
news
Novartis candidate vaccine Bexsero® shows potential against meningococcal serogroup B infections
10 June 2011 | By Novartis
New data from a pivotal study in more than 1,800 infants...
